Improved process design for monoclonal antibody charge variants separation with multicolumn counter-current solvent gradient purification.

Charge variants Continuous chromatography Monoclonal antibody Process design Purification

Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
27 Sep 2023
Historique:
received: 16 05 2023
revised: 30 07 2023
accepted: 08 08 2023
medline: 7 9 2023
pubmed: 17 8 2023
entrez: 16 8 2023
Statut: ppublish

Résumé

The multicolumn counter-current solvent gradient purification (MCSGP) method has proven effective in addressing the issue of elution profile overlap for difficult-to-separate proteins, leading to improved purity and recovery. However, during the MCSGP process, the flow rate and proportion of loaded proteins undergo changes, causing a significant discrepancy between the elution profiles of batch process design and the actual MCSGP process. This mismatch negatively impacts the purity and recovery of the target protein. To address this challenge, an improved process design (reDesign) was proposed with the first-run MCSGP to mimic the actual continuous process and obtain elution profiles that closely resemble the real ones. The reDesign was demonstrated with both a model protein mixture and a sample of monoclonal antibody (mAb) with charge variants. For model protein mixture, the reDesign-based MCSGP process (reMCSGP) showed a remarkable improvement in recovery, increasing from 83.6% to 97.8% while maintaining a purity of more than 95%. For mAb sample, the recovery of reMCSGP improved significantly to 93.9%, surpassing the performance of normal MCSGP processes at a given purity level of more than 84%. In general, the new process design strategy developed in this work could generate a more representative elution profile that closely mirrors actual conditions in continuous processes, which enhances the separation performance of MCSGP.

Identifiants

pubmed: 37586302
pii: S0021-9673(23)00517-4
doi: 10.1016/j.chroma.2023.464292
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Solvents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

464292

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Shu-Ying Jing (SY)

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Zhejiang Key Laboratory of Smart Biomaterials, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.

Ce Shi (C)

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Zhejiang Key Laboratory of Smart Biomaterials, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.

Dong Gao (D)

Hisun Biopharmaceutical Co., Ltd., Hangzhou 311404, China.

Hai-Bin Wang (HB)

Hisun Biopharmaceutical Co., Ltd., Hangzhou 311404, China.

Shan-Jing Yao (SJ)

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Zhejiang Key Laboratory of Smart Biomaterials, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.

Dong-Qiang Lin (DQ)

Key Laboratory of Biomass Chemical Engineering of Ministry of Education, Zhejiang Key Laboratory of Smart Biomaterials, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China. Electronic address: lindq@zju.edu.cn.

Articles similaires

Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Antigen targeting and anti-tumor activity of a novel anti-CD146

Kim Lindland, Marion Masitsa Malenge, Ruth Gong Li et al.
1.00
Animals Humans CD146 Antigen Mice Immunoconjugates

Comparative assessment of physics-based in silico methods to calculate relative solubilities.

Adiran Garaizar Suarez, Andreas H Göller, Michael E Beck et al.
1.00
Solvents Solubility Quantum Theory Molecular Dynamics Simulation Thermodynamics

Classifications MeSH